IBBY, to be fair a biotech research company relies on successful research which in turn
relies on successful trial results.....These trials need to be funded somehow, couple of ways
to do this, raise capital from investors or sell yourselves short....Management have alleviated
costs to an extent through collaborative agreements...I don't know what else they can do....
In saying that I do question the timing of this latest placement of which I will be questioning
management this morning....When I get a reply I will pass it on....Have a great break my friend.
2 cent party, page-37
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.020(7.02%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $1.171M | 3.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101067 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8068 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
